Results 11 to 20 of about 29,707 (225)
Frontiers in Immunology, 2021 BackgroundAnti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a small vessel vasculitis in adults and children that commonly affects the kidneys.
Kristen M. Gibson +9 more
doaj +1 more source
Renal thrombotic microangiopathy in an ANCA-associated vasculitis [PDF]
Journal of Nephropathology, 2019 Anti-neutrophil cytoplasmic antibody (ANCA) disease remains a diagnostic challenge due to the heterogeneity of possible clinical presentations. We present the case of a 63-year-old white male with a known history of ANCA-associated vasculitis (AAV) with ...
Ana Teresa Domingos +5 more
doaj +1 more source
Archives of Medical Science, 2020 Introduction Anti-neutrophilic cytoplasmic antibody (ANCA) has been reported in systemic sclerosis (SSc). Some clinical features of SSc can also be presented with ANCA-associated vasculitis.
Ajanee Mahakkanukrauh +3 more
doaj +1 more source
The Diagnostic and Clinical Utility of Autoantibodies in Systemic Vasculitis
Antibodies, 2019 Considerable progress has been made in understanding the role of autoantibodies in systemic vasculitides (SV), and consequently testing for anti-neutrophil cytoplasmic antibodies (ANCA), anti-glomerular basement membrane antibodies (anti-GBM), and anti ...
Elena Csernok
doaj +1 more source
ANCA Associated Vasculitis Treated with Ultra-low Dose Rituximab: A Case Report
Xiehe Yixue Zazhi, 2023 We reported a case of ANCA-associated vasculitis with pulmonary and renal involvement that was effectively treated with glucocorticoids, cyclophosphamide, and plasma exchange therapy.
WU Haiting, LI Hang
doaj +1 more source
Characterizing infection in anti-neutrophil cytoplasmic antibody-associated vasculitis:results from a longitudinal, matched-cohort data linkage study [PDF]
, 2020 Objectives: Infection exerts a major burden in ANCA-associated vasculitis (AAV), however, its precise extent and nature remains unclear. In this national study we aimed to longitudinally quantify, characterize and contextualize infection risk in AAV ...
Amft, Nicole +11 more
core +6 more sources
Checkpoint inhibitor-related renal vasculitis and use of rituximab
Journal for ImmunoTherapy of Cancer, 2020 The percentage of patients with cancer eligible for checkpoint inhibitor (CPI) therapy has increased rapidly over the past few years and approaches 45%.
Noha Abdel-Wahab +6 more
doaj +1 more source
ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review
European Journal of Medical Research, 2021 Background Systemic sclerosis (SSc) and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) both affect the kidney and may cause renal failure. Treatment of AAV is dramatically different from that of SSc renal crisis (SRC).
Rui Wu, Jiang Su, Yu-rong Zou, Jing Zhu
doaj +1 more source
Incidence of ANCA-associated vasculitis in a UK mixed ethnicity population [PDF]
, 2016 Objectives: We aimed to estimate the incidence of ANCA-associated vasculitis in the UK and how this varied by ethnic group. Methods: We identified incident cases of ANCA-associated vasculitis between March 2007 and June 2013 in the Nottingham–Derby ...
Alfred Mahr +10 more
core +1 more source
Clinic manifestations in granulomatosis with polyangiitis [PDF]
, 2016 Granulomatosis with polyangiitis (GPA), formerly Wegener's granulomatosis (WG), is an uncommon immunologically mediated systemic small-vessel vasculitis that is pathologically characterised by an inflammatory reaction pattern (necrosis, granulomatous ...
De Vincentiis, Marco +7 more
core +1 more source